{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T01:12:20Z","timestamp":1778721140826,"version":"3.51.4"},"reference-count":92,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002713","name":"Imam Mohammed Ibn Saud Islamic University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002713","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100023673","name":"Imam Mohammed Ibn Saud Islamic University Deanship of Scientific Research","doi-asserted-by":"publisher","award":["IMSIU-DDRSP2601"],"award-info":[{"award-number":["IMSIU-DDRSP2601"]}],"id":[{"id":"10.13039\/501100023673","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.bioorg.2026.109863","type":"journal-article","created":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T23:48:20Z","timestamp":1776383300000},"page":"109863","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Receptor-interacting protein kinase 2 (RIPK2): Structural insights, pathophysiological roles, and medicinal chemistry advances in inhibitor design"],"prefix":"10.1016","volume":"176","author":[{"given":"Ahmed A.","family":"Al-Karmalawy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed E.","family":"Eissa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tarek A.","family":"Yousef","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arwa Omar","family":"Al Khatib","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samia S.","family":"Hawas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"21","key":"10.1016\/j.bioorg.2026.109863_bb0040","doi-asserted-by":"crossref","first-page":"14391","DOI":"10.1021\/acs.jmedchem.3c00593","article-title":"Receptor interacting Ser\/Thr-protein kinase 2 as a new therapeutic target","volume":"66","author":"Rivoal","year":"2023","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2026.109863_bb0045","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.dci.2014.09.006","article-title":"Functional characterization of receptor-interacting serine\/threonine kinase 2 (RIP2) of the goldfish (carassius auratus l.)","volume":"48","author":"Xie","year":"2015","journal-title":"Dev. Comparat. Immunol."},{"key":"10.1016\/j.bioorg.2026.109863_bb0050","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.phrs.2018.10.016","article-title":"Gene silencing of receptor-interacting protein 2 protects against cigarette smoke-induced acute lung injury","volume":"139","author":"Dong","year":"2019","journal-title":"Pharmacol. Res."},{"issue":"2","key":"10.1016\/j.bioorg.2026.109863_bb0055","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s12104-016-9675-x","article-title":"NMR resonance assignments of caspase recruitment domain of RIP2 kinase","volume":"10","author":"Lin","year":"2016","journal-title":"Biomol. NMR Assign."},{"issue":"6","key":"10.1016\/j.bioorg.2026.109863_bb0060","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.molimm.2008.11.002","article-title":"RIP2-\u03b2: a novel alternative mRNA splice variant of the receptor interacting protein kinase RIP2","volume":"46","author":"Krieg","year":"2009","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.bioorg.2026.109863_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2024.117967","article-title":"The application of PROTACs in immune-inflammation diseases","volume":"115","author":"Zhang","year":"2024","journal-title":"Bioorg. Med. Chem."},{"issue":"3","key":"10.1016\/j.bioorg.2026.109863_bb0070","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1080\/15548627.2023.2166724","article-title":"RIPosomes are targets of IRGM-SQSTM1-dependent autophagy","volume":"19","author":"Mehto","year":"2023","journal-title":"Autophagy"},{"issue":"8","key":"10.1016\/j.bioorg.2026.109863_bb0075","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1039\/C5MB00212E","article-title":"Structural and functional insights into CARDs of zebrafish (danio rerio) NOD1 and NOD2, and their interaction with adaptor protein RIP2","volume":"11","author":"Maharana","year":"2015","journal-title":"Mol. Biosyst."},{"issue":"1","key":"10.1016\/j.bioorg.2026.109863_bb0085","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1039\/D4NJ04376F","article-title":"Unveiling the anti-inflammatory potential of organoselenium schiff bases: computational and in vitro studies","volume":"49","author":"Shaaban","year":"2025","journal-title":"New J. Chem."},{"issue":"2","key":"10.1016\/j.bioorg.2026.109863_bb0090","doi-asserted-by":"crossref","DOI":"10.1002\/ddr.70075","article-title":"Innovative multitarget organoselenium hybrids with apoptotic and anti-inflammatory properties acting as JAK1\/STAT3 suppressors","volume":"86","author":"Shaaban","year":"2025","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.bioorg.2026.109863_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2024.122688","article-title":"Coenzyme q10 mitigates cadmium cardiotoxicity by downregulating NF-\u03baB\/NLRP3 inflammasome axis and attenuating oxidative stress in mice","volume":"348","author":"Antar","year":"2024","journal-title":"Life Sci."},{"issue":"44","key":"10.1016\/j.bioorg.2026.109863_bb0100","doi-asserted-by":"crossref","first-page":"31990","DOI":"10.1039\/D4RA04762A","article-title":"Investigating the anti-inflammatory potential of n-amidic acid organoselenium candidates: biological assessments, molecular docking, and molecular dynamics simulations","volume":"14","author":"Althikrallah","year":"2024","journal-title":"RSC Adv."},{"key":"10.1016\/j.bioorg.2026.109863_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115180","article-title":"4-(5-amino-pyrazol-1-yl)benzenesulfonamide derivatives as novel multi-target anti-inflammatory agents endowed with inhibitory activity against COX-2, 5-LOX and carbonic anhydrase: design, synthesis, and biological assessments","volume":"250","author":"Ragab","year":"2023","journal-title":"Eur. J. Med. Chem."},{"issue":"4","key":"10.1016\/j.bioorg.2026.109863_bb0110","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24044004","article-title":"Fibrosis: types, effects, markers, mechanisms for disease progression, and its relation with oxidative stress, immunity, and inflammation","volume":"24","author":"Antar","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2026.109863_bb0115","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s00210-025-04393-4","article-title":"Targeting AMPK with ivabradine attenuates cyclophosphamide-induced hepatotoxicity: crosstalk with MAPK, JAK1\/STAT3, and PI3K\/Akt pathways","volume":"399","author":"El-Dessouki","year":"2025","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.bioorg.2026.109863_bb0120","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ejphar.2014.05.030","article-title":"Zinc oxide nanoparticles, a novel candidate for the treatment of allergic inflammatory diseases","volume":"738","author":"Kim","year":"2014","journal-title":"Eur. J. Pharmacol."},{"issue":"10","key":"10.1016\/j.bioorg.2026.109863_bb0125","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1038\/sj.ki.5002534","article-title":"Receptor-interacting protein 2 is a marker for resolution of peritoneal dialysis-associated peritonitis","volume":"72","author":"McCully","year":"2007","journal-title":"Kidney Int."},{"issue":"1","key":"10.1016\/j.bioorg.2026.109863_bb0130","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/s41420-024-02213-x","article-title":"N4BP3 facilitates NOD2-MAPK\/NF-\u03baB pathway in inflammatory bowel disease through mediating k63-linked RIPK2 ubiquitination","volume":"10","author":"Jiang","year":"2024","journal-title":"Cell Death Discovery"},{"issue":"1","key":"10.1016\/j.bioorg.2026.109863_bb0135","doi-asserted-by":"crossref","first-page":"6442","DOI":"10.1038\/ncomms7442","article-title":"A RIPK2 inhibitor delays NOD signalling events yet prevents inflammatory cytokine production","volume":"6","author":"Nachbur","year":"2015","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.bioorg.2026.109863_bb0025","doi-asserted-by":"crossref","first-page":"3708","DOI":"10.1016\/j.apsb.2025.05.003","article-title":"CMD-OPT model enables the discovery of a potent and selective RIPK2 inhibitor as preclinical candidate for the treatment of acute liver injury","volume":"15","author":"Chen","year":"2025","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.bioorg.2026.109863_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2025.112211","article-title":"RIPK2\/STAT3 signaling axis drives lung cancer metastasis through SNAIL activation: molecular mechanisms and clinical implications","volume":"138","author":"Liu","year":"2026","journal-title":"Cell. Signal."},{"issue":"1","key":"10.1016\/j.bioorg.2026.109863_bb0145","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s12920-022-01239-3","article-title":"A pancancer analysis of the carcinogenic role of receptor-interacting serine\/threonine protein kinase-2 (RIPK2) in human tumours","volume":"15","author":"Zhang","year":"2022","journal-title":"BMC Med. Genomics"},{"key":"10.1016\/j.bioorg.2026.109863_bb0150","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1192970","article-title":"RIPK2: a promising target for cancer treatment","volume":"14","author":"You","year":"2023","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.bioorg.2026.109863_bb0155","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-025-07599-9","article-title":"RIPK2 promotes colorectal cancer metastasis by protecting YAP degradation from ITCH-mediated ubiquitination","volume":"16","author":"Lu","year":"2025","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bioorg.2026.109863_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.108285","article-title":"Novel inhibitors of oncogenic Wnt\/TCF-4\/\u03b2-catenin signaling pathway: design, synthesis, molecular docking studies and apoptosis inducing activity of pyrimidothiazino-, dihydropyrimidotriazepino- and 1,3,4-thiadiazolopyrimido-indole hybrids","volume":"157","author":"Mourad","year":"2025","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.109863_bb0165","doi-asserted-by":"crossref","first-page":"17989","DOI":"10.1007\/s00210-025-04196-7","article-title":"Cytotoxic and proapoptotic effects of alizarin in mice with ehrlich solid tumor: novel insights into ER\u03b1-mediated MDM2\/p-Rb\/E2F1 signaling pathway","volume":"398","author":"Eid","year":"2025","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"issue":"1","key":"10.1016\/j.bioorg.2026.109863_bb0170","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/s41467-022-28340-6","article-title":"Receptor-interacting protein kinase 2 (RIPK2) stabilizes c-Myc and is a therapeutic target in prostate cancer metastasis","volume":"13","author":"Yan","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioorg.2026.109863_bb0175","article-title":"Knockdown of RIPK2 inhibits proliferation and migration, and induces apoptosis via the NF-\u03baB signaling pathway in gastric cancer","volume":"12","author":"Yang","year":"2021","journal-title":"Front. Genet."},{"key":"10.1016\/j.bioorg.2026.109863_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2025.102424","article-title":"RIP2\/NF-\u03baB\/PD-L1 signaling pathway is involved in temozolomide resistance by inducing autophagy in glioblastoma cells","volume":"58","author":"Liu","year":"2025","journal-title":"Transl. Oncol."},{"issue":"1","key":"10.1016\/j.bioorg.2026.109863_bb0185","first-page":"47","article-title":"Pan-cancer analysis reveals RIPK2 predicts prognosis and promotes immune therapy resistance via triggering cytotoxic T lymphocytes dysfunction","volume":"28","author":"Song","year":"2022","journal-title":"Mol. Med. (Cambridge, Mass.)."},{"key":"10.1016\/j.bioorg.2026.109863_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.108159","article-title":"Design and synthesis of new 1,2,3-triazole derivatives as VEGFR-2\/telomerase downregulatory candidates endowed with apoptotic potential for cancer treatment","volume":"156","author":"Al-Karmalawy","year":"2025","journal-title":"Bioorg. Chem."},{"issue":"14","key":"10.1016\/j.bioorg.2026.109863_bb0195","doi-asserted-by":"crossref","first-page":"6025","DOI":"10.1039\/D5NJ00367A","article-title":"Exploring the anticancer potential of new pyrazolopyrimidine analogues as multi-target directed EGFR\/STAT3 downregulatory candidates with apoptotic potential","volume":"49","author":"Al-Karmalawy","year":"2025","journal-title":"New J. Chem."},{"issue":"26","key":"10.1016\/j.bioorg.2026.109863_bb0200","doi-asserted-by":"crossref","first-page":"18576","DOI":"10.1039\/D4RA02944E","article-title":"Repurposed organoselenium tethered amidic acids as apoptosis inducers in melanoma cancer via p53, BAX, caspases-3, 6, 8, 9, BCL-2, MMP2, and MMP9 modulations","volume":"14","author":"Shaaban","year":"2024","journal-title":"RSC Adv."},{"key":"10.1016\/j.bioorg.2026.109863_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107223","article-title":"Multi-target rational design and synthesis of novel diphenyl-tethered pyrazolopyrimidines targeting EGFR and topoisomerase II with potential DNA intercalation and apoptosis induction","volume":"145","author":"Gaber","year":"2024","journal-title":"Bioorg. Chem."},{"issue":"4","key":"10.1016\/j.bioorg.2026.109863_bb0210","doi-asserted-by":"crossref","DOI":"10.1002\/ddr.22197","article-title":"Design and synthesis of novel tetrabromophthalimide derivatives as potential tubulin inhibitors endowed with apoptotic induction for cancer treatment","volume":"85","author":"Abdel-Motaal","year":"2024","journal-title":"Drug Dev. Res."},{"issue":"1","key":"10.1016\/j.bioorg.2026.109863_bb0215","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s13048-022-00986-2","article-title":"High expression of RIPK2 is associated with taxol resistance in serous ovarian cancer","volume":"15","author":"Shen","year":"2022","journal-title":"J. Ovarian Res."},{"issue":"1","key":"10.1016\/j.bioorg.2026.109863_bb0220","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s41392-020-00443-w","article-title":"Metabolism pathways of arachidonic acids: mechanisms and potential therapeutic targets","volume":"6","author":"Wang","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bioorg.2026.109863_bb0225","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1369726","article-title":"An inflammation-related subtype classification for analyzing tumor microenvironment and clinical prognosis in colorectal cancer","volume":"15","author":"Pei","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bioorg.2026.109863_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2023.129567","article-title":"Design, synthesis and evaluation of novel thieno[2,3d]pyrimidine derivatives as potent and specific RIPK2 inhibitors","volume":"97","author":"Misehe","year":"2024","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2026.109863_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113252","article-title":"Design of pyrido[2,3-d]pyrimidin-7-one inhibitors of receptor interacting protein kinase-2 (RIPK2) and nucleotide-binding oligomerization domain (NOD) cell signaling","volume":"215","author":"Nikhar","year":"2021","journal-title":"Eur. J. Med. Chem."},{"issue":"21","key":"10.1016\/j.bioorg.2026.109863_bb0015","doi-asserted-by":"crossref","first-page":"7000","DOI":"10.1016\/j.bmc.2015.09.038","article-title":"Crystal structures of human RIP2 kinase catalytic domain complexed with ATP-competitive inhibitors: foundations for understanding inhibitor selectivity","volume":"23","author":"Charnley","year":"2015","journal-title":"Bioorg. Med. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2026.109863_bb0020","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1080\/14756366.2022.2148317","article-title":"Design, synthesis and biological evaluation of 4-aminoquinoline derivatives as receptor-interacting protein kinase 2 (RIPK2) inhibitors","volume":"38","author":"Fan","year":"2023","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109863_bb0030","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1127722","article-title":"Recent advances in the development of RIPK2 modulators for the treatment of inflammatory diseases","volume":"14","author":"Pham","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bioorg.2026.109863_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2022.128968","article-title":"Design, synthesis, and structure-activity relationship of novel RIPK2 inhibitors","volume":"75","author":"Wu","year":"2022","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"11","key":"10.1016\/j.bioorg.2026.109863_bb0080","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1016\/j.celrep.2015.02.052","article-title":"Structure guided design of potent and selective Ponatinib-based hybrid inhibitors for RIPK1","volume":"10","author":"Najjar","year":"2015","journal-title":"Cell Rep."},{"issue":"9","key":"10.1016\/j.bioorg.2026.109863_bb0230","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/j.chembiol.2015.07.017","article-title":"Inflammatory signaling by NOD-RIPK2 is inhibited by clinically relevant type II kinase inhibitors","volume":"22","author":"Canning","year":"2015","journal-title":"Chem. Biol."},{"key":"10.1016\/j.bioorg.2026.109863_bb0235","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.gene.2019.02.047","article-title":"Lnc TINCR induced by NOD1 mediates inflammatory response in 3T3-L1 adipocytes","volume":"698","author":"Fang","year":"2019","journal-title":"Gene"},{"key":"10.1016\/j.bioorg.2026.109863_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112417","article-title":"Receptor-interacting protein kinase 2 (RIPK2) and nucleotide-binding oligomerization domain (NOD) cell signaling inhibitors based on a 3,5-diphenyl-2-aminopyridine scaffold","volume":"200","author":"Suebsuwong","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109863_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.117932","article-title":"Development of thieno[3,2-d]pyrimidine derivatives as potent RIPK2 inhibitors with prominent in vitro and in vivo anti-inflammatory efficacy","volume":"297","author":"Zhao","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109863_bb0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2024.102182","article-title":"RIPK2 and lysosomal pathway: unveiling a new mechanism for lung cancer metastasis","volume":"51","author":"Liu","year":"2025","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.bioorg.2026.109863_bb0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbas.2025.100135","article-title":"Effects of global ripk2 genetic deficiency in aged mice following experimental ischemic stroke","volume":"7","author":"Howell","year":"2025","journal-title":"Aging Brain"},{"issue":"5","key":"10.1016\/j.bioorg.2026.109863_bb0260","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.str.2018.04.002","article-title":"Crystal structure of ripk4 reveals dimerization-dependent kinase activity","volume":"26","author":"Huang","year":"2018","journal-title":"Structure"},{"issue":"5","key":"10.1016\/j.bioorg.2026.109863_bb0265","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0177161","article-title":"Structures of the inactive and active states of RIP2 kinase inform on the mechanism of activation","volume":"12","author":"Pellegrini","year":"2017","journal-title":"PloS One"},{"key":"10.1016\/j.bioorg.2026.109863_bb0270","doi-asserted-by":"crossref","first-page":"208","DOI":"10.3389\/fcell.2019.00208","article-title":"NOD signaling and cell death","volume":"7","author":"Heim","year":"2019","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.bioorg.2026.109863_bb0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.110128","article-title":"RIPK2 as a promising druggable target for autoimmune diseases","volume":"118","author":"Zhao","year":"2023","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.bioorg.2026.109863_bb0280","doi-asserted-by":"crossref","first-page":"1492807","DOI":"10.3389\/fnmol.2025.1492807","article-title":"Current advances on RIPK2 and its inhibitors in pathological processes: a comprehensive review","volume":"18","author":"Shen","year":"2025","journal-title":"Front. Mol. Neurosci."},{"issue":"10","key":"10.1016\/j.bioorg.2026.109863_bb0285","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1021\/acsmedchemlett.7b00258","article-title":"Identification of potent and selective RIPK2 inhibitors for the treatment of inflammatory diseases","volume":"8","author":"He","year":"2017","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2026.109863_bb0290","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.semcdb.2020.07.001","article-title":"RIPK2 NODs to XIAP and IBD","volume":"109","author":"Topal","year":"2021","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.bioorg.2026.109863_bb0295","series-title":"Comprehensive Medicinal Chemistry III","first-page":"395","article-title":"5.12 - evolution of small-molecule immunology research\u2014changes since CMC II","author":"Dhar","year":"2017"},{"issue":"1","key":"10.1016\/j.bioorg.2026.109863_bb0300","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s13578-022-00810-w","article-title":"Application and prospect of targeting innate immune sensors in the treatment of autoimmune diseases","volume":"12","author":"Liu","year":"2022","journal-title":"Cell Biosci."},{"issue":"1","key":"10.1016\/j.bioorg.2026.109863_bb0305","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.semarthrit.2012.12.005","article-title":"Nucleotide-binding oligomerization domain containing 2: structure, function, and diseases","volume":"43","author":"Yao","year":"2013","journal-title":"Semin. Arthritis Rheum."},{"issue":"1","key":"10.1016\/j.bioorg.2026.109863_bb0310","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1038\/s42003-023-05353-5","article-title":"Repurposing of ibrutinib and quizartinib as potent inhibitors of necroptosis","volume":"6","author":"Huang","year":"2023","journal-title":"Commun. Biol."},{"key":"10.1016\/j.bioorg.2026.109863_bb0315","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2022.101841","article-title":"Kinases control of regulated cell death revealing druggable targets for parkinsons disease","volume":"85","author":"Mansour","year":"2023","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.bioorg.2026.109863_bb0320","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.semcdb.2020.06.014","article-title":"RIPK protein kinase family: atypical lives of typical kinases","volume":"109","author":"Cuny","year":"2021","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.bioorg.2026.109863_bb0325","first-page":"1372376","article-title":"RIPK2: a promising target for, oncogenic PI3KT\/Akt\/mTOR pathway alterations, ROS homeostasis, targeted cancer therapy and drug resistance","volume":"14","author":"You","year":"2025","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bioorg.2026.109863_bb0330","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115717","article-title":"Exploring positions 6 and 7 of a quinazoline-based scaffold leads to changes in selectivity and potency towards RIPK2\/3 kinases","volume":"260","author":"Misehe","year":"2023","journal-title":"Eur. J. Med. Chem."},{"issue":"8","key":"10.1016\/j.bioorg.2026.109863_bb0335","doi-asserted-by":"crossref","DOI":"10.1002\/ddr.70192","article-title":"Next-generation proteolysis-targeting chimeras in precision oncology: multifunctional designs, emerging modalities, and translational prospects in targeted protein degradation","volume":"86","author":"Nafie","year":"2025","journal-title":"Drug Dev. Res."},{"issue":"15","key":"10.1016\/j.bioorg.2026.109863_bb0340","doi-asserted-by":"crossref","first-page":"8355","DOI":"10.1021\/jacs.2c11715","article-title":"A cell type selective YM155 prodrug targets receptor-interacting protein kinase 2 to induce brain cancer cell death","volume":"145","author":"West","year":"2023","journal-title":"J. Am. Chem. Soc."},{"issue":"1","key":"10.1016\/j.bioorg.2026.109863_bb0345","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/s42003-020-0868-6","article-title":"Extended pharmacodynamic responses observed upon PROTAC-mediated degradation of RIPK2","volume":"3","author":"Mares","year":"2020","journal-title":"Commun. Biol."},{"issue":"2","key":"10.1016\/j.bioorg.2026.109863_bb0350","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1002\/med.21992","article-title":"The new direction of drug development: degradation of undruggable targets through targeting chimera technology","volume":"44","author":"Liang","year":"2024","journal-title":"Med. Res. Rev."},{"issue":"10","key":"10.1016\/j.bioorg.2026.109863_bb0355","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.70401","article-title":"Proteolysis-targeting chimera (PROTAC): current applications and future directions","volume":"6","author":"Fan","year":"2025","journal-title":"MedComm"},{"key":"10.1016\/j.bioorg.2026.109863_bb0360","article-title":"Proteolysis-targeting chimera (PROTAC): current applications and future directions","volume":"10","author":"Fan","year":"2025","journal-title":"6"},{"issue":"13","key":"10.1016\/j.bioorg.2026.109863_bb0365","doi-asserted-by":"crossref","first-page":"9312","DOI":"10.1021\/acs.jmedchem.2c00604","article-title":"Discovery of potent and selective receptor-interacting serine\/threonine protein kinase 2 (RIPK2) inhibitors for the treatment of inflammatory bowel diseases (IBDs)","volume":"65","author":"Yuan","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109863_bb0370","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115647","article-title":"Discovery of a novel RIPK2 inhibitor for the treatment of inflammatory bowel disease","volume":"214","author":"Lai","year":"2023","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bioorg.2026.109863_bb0375","doi-asserted-by":"crossref","unstructured":"J.V. Cruz, M.F.A. Neto, L.B. Silva, R. Da S. Ramos, J. Da S. Costa, D.S.B. Brasil, C.C. Lobato, G.V. Da Costa, J.A.H.M. Bittencourt, C.H.T.P. Da Silva, F.H.A. Leite, C.B.R. Santos, Identification of novel protein kinase receptor type 2 inhibitors using pharmacophore and structure-based virtual screening, Molecules (Basel, Switzerland) 23 (2018) 453.","DOI":"10.3390\/molecules23020453"},{"issue":"4","key":"10.1016\/j.bioorg.2026.109863_bb0380","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.bmcl.2018.01.044","article-title":"Activation loop targeting strategy for design of receptor-interacting protein kinase 2 (RIPK2) inhibitors","volume":"28","author":"Suebsuwong","year":"2018","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"2","key":"10.1016\/j.bioorg.2026.109863_bb0385","doi-asserted-by":"crossref","DOI":"10.1002\/cmdc.202400567","article-title":"Towards new anti-inflammatory agents: design, synthesis and evaluation of molecules targeting XIAP-BIR2","volume":"20","author":"Farag","year":"2025","journal-title":"ChemMedChem"},{"issue":"17","key":"10.1016\/j.bioorg.2026.109863_bb0390","doi-asserted-by":"crossref","first-page":"12978","DOI":"10.1021\/acs.jmedchem.1c01118","article-title":"Optimization of a series of RIPK2 PROTACs","volume":"64","author":"Miah","year":"2021","journal-title":"J. Med. Chem."},{"issue":"21","key":"10.1016\/j.bioorg.2026.109863_bb0395","doi-asserted-by":"crossref","first-page":"19428","DOI":"10.1021\/acs.jmedchem.4c01767","article-title":"Design, synthesis, and activity evaluation of BRD4 PROTAC based on alkenyl Oxindole-DCAF11 pair","volume":"67","author":"Zhao","year":"2024","journal-title":"J. Med. Chem."},{"issue":"7","key":"10.1016\/j.bioorg.2026.109863_bb0400","doi-asserted-by":"crossref","first-page":"7539","DOI":"10.1021\/acs.jmedchem.4c03226","article-title":"Discovery of potent and balanced dual RIPK2 and 3 inhibitors as a new strategy for the treatment of inflammatory bowel diseases","volume":"68","author":"Ma","year":"2025","journal-title":"J. Med. Chem."},{"issue":"19","key":"10.1016\/j.bioorg.2026.109863_bb0405","doi-asserted-by":"crossref","first-page":"17407","DOI":"10.1021\/acs.jmedchem.4c01313","article-title":"New potent RIPK2 inhibitors as a promising therapeutic avenue for colitis through the blockade of NOD inflammatory pathways","volume":"67","author":"Rivoal","year":"2024","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2026.109863_bb0410","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1021\/acs.jmedchem.3c02102","article-title":"From hit to lead: structure-based optimization of novel selective inhibitors of receptor-interacting protein kinase 1 (RIPK1) for the treatment of inflammatory diseases","volume":"67","author":"Zhang","year":"2024","journal-title":"J. Med. Chem."},{"issue":"6","key":"10.1016\/j.bioorg.2026.109863_bb0415","doi-asserted-by":"crossref","first-page":"421","DOI":"10.4155\/fmc-2021-0196","article-title":"Synthesis and characterization of potent RIPK3 inhibitors based on a tricyclic scaffold","volume":"14","author":"Wu","year":"2022","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109863_bb0420","doi-asserted-by":"crossref","unstructured":"C.-h. Hu, Y. Chen, T.-y. Jin, Z. Wang, B. Jin, J. Liao, C.-y. Ding, A. Zhang, W.-y. Tang, L.-x. Zhang, L.-y. Xu, F.-m. Ning, G. Liang, X.-h. Wei, Y. Wang, A derivative of tanshinone IIA and salviadione, 15a, inhibits inflammation and alleviates DSS-induced colitis in mice by direct binding and inhibition of RIPK2, Acta Pharmacol. Sin. 46(3) (2025) 672\u2013686.","DOI":"10.1038\/s41401-024-01399-1"},{"issue":"17","key":"10.1016\/j.bioorg.2026.109863_bb0425","doi-asserted-by":"crossref","DOI":"10.15252\/embj.201899372","article-title":"Small molecule inhibitors reveal an indispensable scaffolding role of RIPK2 in NOD2 signaling","volume":"37","author":"Hrdinka","year":"2018","journal-title":"EMBO J."},{"issue":"11","key":"10.1016\/j.bioorg.2026.109863_bb0430","doi-asserted-by":"crossref","DOI":"10.15252\/embr.202050400","article-title":"A regulatory region on RIPK2 is required for XIAP binding and NOD signaling activity","volume":"21","author":"Heim","year":"2020","journal-title":"EMBO Rep."},{"key":"10.1016\/j.bioorg.2026.109863_bb0435","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.3390\/cells9051118","article-title":"IAP-mediated protein ubiquitination in regulating cell signaling","volume":"9","author":"Dum\u00e9tier","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.bioorg.2026.109863_bb0440","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3390\/immuno5030037","article-title":"RIPK2 inhibition blocks NOD2-mediated IL-1\u03b2 production by macrophages in vitro but exacerbates crohns disease-like ileitis in SHIP\u2212\/\u2212 mice","volume":"5","author":"Pang","year":"2025","journal-title":"Immuno"},{"key":"10.1016\/j.bioorg.2026.109863_bb0445","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106647","article-title":"Analysis on benzothiazole necroptosis inhibitors with chiral substitutions in the solvent-accessible region of RIP kinase domain","volume":"137","author":"Shao","year":"2023","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.109863_bb0450","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115683","article-title":"RIPK2 inhibitors for disease therapy: current status and perspectives","volume":"259","author":"Tian","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109863_bb0455","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.semcdb.2020.08.005","article-title":"The diverse roles of RIP kinases in host-pathogen interactions","volume":"109","author":"Eng","year":"2021","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.bioorg.2026.109863_bb0460","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2022.116916","article-title":"The protective effects of natural product tunicatachalcone against neuroinflammation via targeting RIPK2 in microglia BV-2 cells stimulated by LPS","volume":"69","author":"Wen","year":"2022","journal-title":"Bioorg. Med. Chem."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826003998?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826003998?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T00:36:58Z","timestamp":1778719018000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206826003998"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":92,"alternative-id":["S0045206826003998"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.109863","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Receptor-interacting protein kinase 2 (RIPK2): Structural insights, pathophysiological roles, and medicinal chemistry advances in inhibitor design","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.109863","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109863"}}